Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
|
|
Shockwave Medical, Inc. (SWAV)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/07/2023 |
8-K
| Quarterly results|
Docs:
|
"Shockwave Medical Reports Second Quarter 2023 Financial Results SANTA CLARA, Calif., Aug. 07, 2023 -- Shockwave Medical, Inc. , a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, today reported financial results for the three months ended June 30, 2023. Recent Highlights Recognized revenue of $180.2 million for the second quarter of 2023, representing an increase of 49% from the same period in 2022 As part of the Fiscal Year 2024 Medicare Hospital Inpatient Prospective Payment System final rule, the Centers for Medicare & Medicaid Services created three new coronary IVL-specific MS-DRGs, which will become effective October 1, 2023. These new codes are associated with higher payments than the MS-DRG payments for o..." |
|
| 05/08/2023 |
8-K
| Quarterly results|
Docs:
|
"Shockwave Medical Reports First Quarter 2023 Financial Results SANTA CLARA, Calif., May 08, 2023 -- Shockwave Medical, Inc. , a pioneer in the development and commercialization of Intravascular Lithotripsy to treat complex calcified cardiovascular disease, today reported financial results for the three months ended March 31, 2023. Recent Highlights Recognized revenue of $161.1 million for the first quarter of 2023, representing an increase of 72% from the same period in 2022 Announced the full U.S. commercial availability of the Shockwave L 6 Peripheral IVL Catheter following clearance by the U.S. Food and Drug Administration Centers for Medicare & Medicaid Services , as part of the calendar year 2024 Medicare Hospital Inpatient Prospective Payment System proposed rule, proposed three newl..." |
|
| 11/07/2022 |
8-K
| Quarterly results |
| 08/08/2022 |
8-K
| Quarterly results |
| 05/09/2022 |
8-K
| Quarterly results |
| 02/17/2022 |
8-K
| Quarterly results|
Docs:
|
"Shockwave Medical Reports Fourth Quarter and Full Year 2021 Financial Results SANTA CLARA, Calif., Feb. 17, 2022 -- Shockwave Medical, Inc. , a pioneer in the development and commercialization of Intravascular Lithotripsy to treat complex calcified cardiovascular disease, today reported financial results for the three months and full year ended December 31, 2021. Recent Highlights Recognized revenue of $84.2 million for the fourth quarter of 2021 and $237.1 million for the full year of 2021, representing increases of 271% and 250%, respectively, from the same periods in 2020 Centers for Medicare & Medicaid Services reassigned the payment for peripheral IVL procedures performed on above the knee arteries in the hospital outpatient setting, thereby meaningfully increasing the payments hospit..." |
|
| 11/08/2021 |
8-K
| Quarterly results |
| 08/09/2021 |
8-K
| Quarterly results |
| 05/10/2021 |
8-K
| Quarterly results |
| 02/17/2021 |
8-K
| Quarterly results |
| 11/10/2020 |
8-K/A
| Quarterly results, Conference call transcript |
| 11/09/2020 |
8-K
| Quarterly results |
| 08/11/2020 |
8-K
| Quarterly results |
| 05/12/2020 |
8-K
| Quarterly results |
| 02/13/2020 |
8-K
| Quarterly results |
| 11/07/2019 |
8-K
| Quarterly results |
| 08/05/2019 |
8-K
| Quarterly results |
| 05/08/2019 |
8-K
| Quarterly results |
|
|